Prologue Medicines
Prologue is designing powerful new medicines by unlocking the viral proteome. The Company鈥檚 state-of-the-art DELVE鈩� Platform systematically identifies and evaluates viral proteins and their unique features for their potential to precisely regulate human physiology. By co-opting viral evolution, Prologue is expanding the functional boundaries of proteins encoded by the human genome to create new programmable medicines. Prologue was founded by 蘑菇视频APP in 2021.